The brokerage firm lifted its rating on the crypto exchange’s shares to market perform from underperform.Technology, news, Coinbase, Stock Market, Analysis, Upgrades, Equities, Raymond james, Goldman Sachs, Wall Street, BrokeragesRead More

You might also be interested in reading Pharming Group outlines 2025 revenue guidance of $315M to $335M driven by RUCONEST and Joenja growth.